[Iodine-123-MIBG scintigraphy in neuroblastoma; relationship between the intensity of uptake and tumor characteristics]
- PMID: 10586543
[Iodine-123-MIBG scintigraphy in neuroblastoma; relationship between the intensity of uptake and tumor characteristics]
Abstract
Iodine-123-MIBG (123I-MIBG) scintigraphy were performed for 23 patients with neuroblastoma at diagnosis. The intensity of MIBG activity in the primary tumor was evaluated visually (grade 3; intense uptake-grade 0; no definite uptake), and its relationship to the size, degree of tumor spread, urinary catecholamine metabolites (VMA, HVA), and histological types were investigated. The results of 123I-MIBG uptake grade were as follows: grade 3; 44% (10/23), grade 2; 30% (7/23), grade 1; 17% (4/23), grade 0; 9% (2/23). The grade was not associated with the tumor size, or the degree of tumor extension to the distant lesion, either. The more catecholamine metabolites were excreted in the urine, the tumor tended to have more intense uptake. The tumors of neuroblastoma rosette fibrillary type, and ganglioneuroblastoma poorly differentiated type had more intense uptake than neuroblastoma round cell type and ganglioneuroblastoma well differentiated type. The case of ganglioneuroma did not have definite MIBG uptake. The intensity of MIBG uptake is not relevant to the pathological grade of neuroblastoma, but considering the electromicroscopical features of neuroblastoma reported previously, it is thought to reflect the histological type.
Similar articles
-
131I-MIBG in the diagnosis of primary and metastatic neuroblastoma.Gulf J Oncolog. 2007 Jul;(2):33-41. Gulf J Oncolog. 2007. PMID: 20084722
-
Indium-111-pentetreotide scintigraphy in children with neuroblast-derived tumors.J Nucl Med. 1996 Jun;37(6):893-6. J Nucl Med. 1996. PMID: 8683306
-
Iodine-131-MIBG imaging to monitor chemotherapy response in advanced neuroblastoma: comparison with laboratory analysis.J Nucl Med. 1994 Sep;35(9):1429-35. J Nucl Med. 1994. PMID: 8071687
-
[MIBG scintigraphy in neuroblastoma: something more than an image].Rev Esp Med Nucl. 2006 Mar-Apr;25(2):118-43. doi: 10.1157/13086257. Rev Esp Med Nucl. 2006. PMID: 16759621 Review. Spanish. No abstract available.
-
MIBG in neuroblastoma diagnosis and treatment.Semin Pediatr Surg. 2019 Dec;28(6):150859. doi: 10.1016/j.sempedsurg.2019.150859. Epub 2019 Nov 20. Semin Pediatr Surg. 2019. PMID: 31931960 Review.
Cited by
-
Combined Scintigraphy and Tumor Marker Analysis Predicts Unfavorable Histopathology of Neuroblastic Tumors with High Accuracy.PLoS One. 2015 Jul 15;10(7):e0132809. doi: 10.1371/journal.pone.0132809. eCollection 2015. PLoS One. 2015. PMID: 26177109 Free PMC article.
-
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.Cochrane Database Syst Rev. 2015 Sep 29;2015(9):CD009263. doi: 10.1002/14651858.CD009263.pub2. Cochrane Database Syst Rev. 2015. PMID: 26417712 Free PMC article.
-
High ¹²³I-MIBG uptake in neuroblastic tumours indicates unfavourable histopathology.Eur J Nucl Med Mol Imaging. 2013 Oct;40(11):1701-10. doi: 10.1007/s00259-013-2491-y. Epub 2013 Jul 16. Eur J Nucl Med Mol Imaging. 2013. PMID: 23857458
-
Iodine-123 Metaiodobenzylguanidine (I-123 MIBG) in Clinical Applications: A Comprehensive Review.Pharmaceuticals (Basel). 2024 Nov 21;17(12):1563. doi: 10.3390/ph17121563. Pharmaceuticals (Basel). 2024. PMID: 39770405 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical